Investor Presentaiton slide image

Investor Presentaiton

Back to Table of Contents LR2: Leverage ratio common disclosure (in $ millions) Q2 2023 Revised Basel III a2 Q1 2023 Basel III аз Q4 2022 Basel III 24 Q3 2022 Basel III On-balance sheet exposures (1) 1 On-balance sheet exposures (excluding derivatives and securities financing transactions (SFTs), but including collateral) 1,138,995 1,076,029 1,061,398 1,030,551 2 Gross-up for derivatives collateral provided where deducted from the balance sheet assets pursuant to the operative accounting framework (IFRS) 3 (Deductions of receivables assets for cash variation margin provided in derivatives transactions) 4 (Asset amounts deducted in determining Basel III Tier 1 capital) 5 Total on-balance sheet exposures (excluding derivatives and SFTs) (sum of rows 1 to 4) (10,835) (11,695) (12,761) (12,364) (15,716) (11,626) (15,054) (13,239) 1,115,399 1,051,970 1,034,056 1,002,258 Derivative exposures 6 Replacement cost associated with all derivatives transactions (where applicable net of eligible cash variation margin and/or with bilateral netting) 23,786 21,828 26,087 25,976 7 Add-on amounts for PFE associated with all derivatives transactions 22,964 22,567 21,129 21,406 8 (Exempted CCP leg of client-cleared trade exposures) 9 Adjusted effective notional amount of written credit derivatives 10 (Adjusted effective notional offsets and add-on deductions for written credit derivatives) 11 Total derivative exposures (sum of rows 6 to 10) 2,669 3,348 1,487 1,708 (1,094) (1,540) (478) (367) 48,325 46,203 48,225 48,723 Securities financing transaction exposures 12 13 Gross SFT assets (with no recognition of netting), after adjusting for sale accounting transactions (Netted amounts of cash payables and cash receivables of gross SFT assets) 14 Counterparty credit risk (CCR) exposure for SFT assets 237,987 218,200 230,893 198,468 (53,303) (39,510) (55,580) (43,251) 10,515 14,258 15,164 16,046 15 Agent transaction exposures 16 Total securities financing transaction exposures (sum of rows 12 to 15) 195,199 192,948 190,477 171,263 Other off-balance sheet exposures 17 Off-balance sheet exposure at gross notional amount 18 (Adjustments for conversion to credit equivalent amounts) 19 Off-balance sheet items (sum of rows 17 and 18) Capital and total exposures 20 Tier 1 capital 21 Total exposures (sum of rows 5, 11, 16 and 19) 522,852 547,048 (351,668) (369,610) 171,184 177,438 541,118 (368,257) 172,861 515,775 (349,196) 166,579 63,688 1,530,107 62,317 61,262 58,801 1,468,559 1,445,619 1,388,823 Leverage ratio 22 Basel III leverage ratio 4.2% 4.2% (1) On-balance sheet items exclude securities purchased under resale agreements and securities borrowed ($184,684MM), derivative financial instruments ($44,725MM), assets outside the regulatory scope of consolidation ($2,284MM). 4.2% 4.2% Scotiabank Supplementary Regulatory Capital Disclosure Page 33 of 88
View entire presentation